trial

Berberine Effect on Cytokine, CRP, Metabolic Disturbance as an Adjunctive Therapy in Schizophrenia Patients

NCTId NCT02936414
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 100 (actual)
Sponsored by Tianjin Anding Hospital
Primary completion 2015-08
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
100 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2014-07
Primary completion
2015-08
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Berberine

Sponsors

Tianjin Anding HospitalLead Sponsor

Sites

1 total
Tianjin, China

Facts & assertions

4 sourced
Enrollment
100
Phase
NA
Primary Completion Date
2015-08
Status
COMPLETED
relationships
The graph out of here
drug
Berberine
drug
lead_sponsor
Tianjin Anding Hospital
company
indication
Schizophrenia
indication
Schizophrenia
indication